Pharma & Healthcare
Global Liposomal Bupivacaine Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4076
- Pages: 75
- Figures: 106
- Views: 41
Liposomal bupivacaine has been approved by the US Food and Drug Administration for local infiltration for pain relief after bunionectomy and hemorrhoidectomy.
The global Liposomal Bupivacaine market is projected to grow from US$ 685 million in 2024 to US$ 930.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Liposomal Bupivacaine gained significant attention and adoption in the medical field due to its potential to reduce the need for opioids for post-operative pain control. This aligns with efforts to combat the opioid epidemic by providing alternative pain management strategies.
Report Covers:
This report presents an overview of global market for Liposomal Bupivacaine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liposomal Bupivacaine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Liposomal Bupivacaine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposomal Bupivacaine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liposomal Bupivacaine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Liposomal Bupivacaine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Segment by Type
20ml
10ml
Segment by Application
Veterinary
Human
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liposomal Bupivacaine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Liposomal Bupivacaine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposomal Bupivacaine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Liposomal Bupivacaine market is projected to grow from US$ 685 million in 2024 to US$ 930.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Liposomal Bupivacaine gained significant attention and adoption in the medical field due to its potential to reduce the need for opioids for post-operative pain control. This aligns with efforts to combat the opioid epidemic by providing alternative pain management strategies.
Report Covers:
This report presents an overview of global market for Liposomal Bupivacaine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liposomal Bupivacaine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Liposomal Bupivacaine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposomal Bupivacaine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Liposomal Bupivacaine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Liposomal Bupivacaine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Segment by Type
20ml
10ml
Segment by Application
Veterinary
Human
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liposomal Bupivacaine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Liposomal Bupivacaine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposomal Bupivacaine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Liposomal Bupivacaine Product Introduction
1.2 Market by Type
1.2.1 Global Liposomal Bupivacaine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 20ml
1.2.3 10ml
1.3 Market by Application
1.3.1 Global Liposomal Bupivacaine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Veterinary
1.3.3 Human
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Liposomal Bupivacaine Sales Estimates and Forecasts 2019-2030
2.2 Global Liposomal Bupivacaine Revenue by Region
2.2.1 Global Liposomal Bupivacaine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Liposomal Bupivacaine Revenue by Region (2019-2024)
2.2.3 Global Liposomal Bupivacaine Revenue by Region (2025-2030)
2.2.4 Global Liposomal Bupivacaine Revenue Market Share by Region (2019-2030)
2.3 Global Liposomal Bupivacaine Sales Estimates and Forecasts 2019-2030
2.4 Global Liposomal Bupivacaine Sales by Region
2.4.1 Global Liposomal Bupivacaine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Liposomal Bupivacaine Sales by Region (2019-2024)
2.4.3 Global Liposomal Bupivacaine Sales by Region (2025-2030)
2.4.4 Global Liposomal Bupivacaine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Liposomal Bupivacaine Sales by Manufacturers
3.1.1 Global Liposomal Bupivacaine Sales by Manufacturers (2019-2024)
3.1.2 Global Liposomal Bupivacaine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liposomal Bupivacaine in 2023
3.2 Global Liposomal Bupivacaine Revenue by Manufacturers
3.2.1 Global Liposomal Bupivacaine Revenue by Manufacturers (2019-2024)
3.2.2 Global Liposomal Bupivacaine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Liposomal Bupivacaine Revenue in 2023
3.3 Global Key Players of Liposomal Bupivacaine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Liposomal Bupivacaine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Liposomal Bupivacaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Liposomal Bupivacaine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Liposomal Bupivacaine, Product Offered and Application
3.8 Global Key Manufacturers of Liposomal Bupivacaine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liposomal Bupivacaine Sales by Type
4.1.1 Global Liposomal Bupivacaine Historical Sales by Type (2019-2024)
4.1.2 Global Liposomal Bupivacaine Forecasted Sales by Type (2025-2030)
4.1.3 Global Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
4.2 Global Liposomal Bupivacaine Revenue by Type
4.2.1 Global Liposomal Bupivacaine Historical Revenue by Type (2019-2024)
4.2.2 Global Liposomal Bupivacaine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
4.3 Global Liposomal Bupivacaine Price by Type
4.3.1 Global Liposomal Bupivacaine Price by Type (2019-2024)
4.3.2 Global Liposomal Bupivacaine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Liposomal Bupivacaine Sales by Application
5.1.1 Global Liposomal Bupivacaine Historical Sales by Application (2019-2024)
5.1.2 Global Liposomal Bupivacaine Forecasted Sales by Application (2025-2030)
5.1.3 Global Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
5.2 Global Liposomal Bupivacaine Revenue by Application
5.2.1 Global Liposomal Bupivacaine Historical Revenue by Application (2019-2024)
5.2.2 Global Liposomal Bupivacaine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
5.3 Global Liposomal Bupivacaine Price by Application
5.3.1 Global Liposomal Bupivacaine Price by Application (2019-2024)
5.3.2 Global Liposomal Bupivacaine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Liposomal Bupivacaine Market Size by Type
6.1.1 US & Canada Liposomal Bupivacaine Sales by Type (2019-2030)
6.1.2 US & Canada Liposomal Bupivacaine Revenue by Type (2019-2030)
6.2 US & Canada Liposomal Bupivacaine Market Size by Application
6.2.1 US & Canada Liposomal Bupivacaine Sales by Application (2019-2030)
6.2.2 US & Canada Liposomal Bupivacaine Revenue by Application (2019-2030)
6.3 US & Canada Liposomal Bupivacaine Market Size by Country
6.3.1 US & Canada Liposomal Bupivacaine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Liposomal Bupivacaine Sales by Country (2019-2030)
6.3.3 US & Canada Liposomal Bupivacaine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Liposomal Bupivacaine Market Size by Type
7.1.1 Europe Liposomal Bupivacaine Sales by Type (2019-2030)
7.1.2 Europe Liposomal Bupivacaine Revenue by Type (2019-2030)
7.2 Europe Liposomal Bupivacaine Market Size by Application
7.2.1 Europe Liposomal Bupivacaine Sales by Application (2019-2030)
7.2.2 Europe Liposomal Bupivacaine Revenue by Application (2019-2030)
7.3 Europe Liposomal Bupivacaine Market Size by Country
7.3.1 Europe Liposomal Bupivacaine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Liposomal Bupivacaine Sales by Country (2019-2030)
7.3.3 Europe Liposomal Bupivacaine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Liposomal Bupivacaine Market Size
8.1.1 China Liposomal Bupivacaine Sales (2019-2030)
8.1.2 China Liposomal Bupivacaine Revenue (2019-2030)
8.2 China Liposomal Bupivacaine Market Size by Application
8.2.1 China Liposomal Bupivacaine Sales by Application (2019-2030)
8.2.2 China Liposomal Bupivacaine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Liposomal Bupivacaine Market Size by Type
9.1.1 Asia Liposomal Bupivacaine Sales by Type (2019-2030)
9.1.2 Asia Liposomal Bupivacaine Revenue by Type (2019-2030)
9.2 Asia Liposomal Bupivacaine Market Size by Application
9.2.1 Asia Liposomal Bupivacaine Sales by Application (2019-2030)
9.2.2 Asia Liposomal Bupivacaine Revenue by Application (2019-2030)
9.3 Asia Liposomal Bupivacaine Sales by Region
9.3.1 Asia Liposomal Bupivacaine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Liposomal Bupivacaine Revenue by Region (2019-2030)
9.3.3 Asia Liposomal Bupivacaine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Liposomal Bupivacaine Market Size by Type
10.1.1 Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Liposomal Bupivacaine Market Size by Application
10.2.1 Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Country
10.3.1 Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pacira Pharmaceuticals
11.1.1 Pacira Pharmaceuticals Company Information
11.1.2 Pacira Pharmaceuticals Overview
11.1.3 Pacira Pharmaceuticals Liposomal Bupivacaine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pacira Pharmaceuticals Liposomal Bupivacaine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pacira Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Liposomal Bupivacaine Industry Chain Analysis
12.2 Liposomal Bupivacaine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposomal Bupivacaine Production Mode & Process
12.4 Liposomal Bupivacaine Sales and Marketing
12.4.1 Liposomal Bupivacaine Sales Channels
12.4.2 Liposomal Bupivacaine Distributors
12.5 Liposomal Bupivacaine Customers
13 Market Dynamics
13.1 Liposomal Bupivacaine Industry Trends
13.2 Liposomal Bupivacaine Market Drivers
13.3 Liposomal Bupivacaine Market Challenges
13.4 Liposomal Bupivacaine Market Restraints
14 Key Findings in The Global Liposomal Bupivacaine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Liposomal Bupivacaine Product Introduction
1.2 Market by Type
1.2.1 Global Liposomal Bupivacaine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 20ml
1.2.3 10ml
1.3 Market by Application
1.3.1 Global Liposomal Bupivacaine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Veterinary
1.3.3 Human
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Liposomal Bupivacaine Sales Estimates and Forecasts 2019-2030
2.2 Global Liposomal Bupivacaine Revenue by Region
2.2.1 Global Liposomal Bupivacaine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Liposomal Bupivacaine Revenue by Region (2019-2024)
2.2.3 Global Liposomal Bupivacaine Revenue by Region (2025-2030)
2.2.4 Global Liposomal Bupivacaine Revenue Market Share by Region (2019-2030)
2.3 Global Liposomal Bupivacaine Sales Estimates and Forecasts 2019-2030
2.4 Global Liposomal Bupivacaine Sales by Region
2.4.1 Global Liposomal Bupivacaine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Liposomal Bupivacaine Sales by Region (2019-2024)
2.4.3 Global Liposomal Bupivacaine Sales by Region (2025-2030)
2.4.4 Global Liposomal Bupivacaine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Liposomal Bupivacaine Sales by Manufacturers
3.1.1 Global Liposomal Bupivacaine Sales by Manufacturers (2019-2024)
3.1.2 Global Liposomal Bupivacaine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liposomal Bupivacaine in 2023
3.2 Global Liposomal Bupivacaine Revenue by Manufacturers
3.2.1 Global Liposomal Bupivacaine Revenue by Manufacturers (2019-2024)
3.2.2 Global Liposomal Bupivacaine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Liposomal Bupivacaine Revenue in 2023
3.3 Global Key Players of Liposomal Bupivacaine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Liposomal Bupivacaine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Liposomal Bupivacaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Liposomal Bupivacaine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Liposomal Bupivacaine, Product Offered and Application
3.8 Global Key Manufacturers of Liposomal Bupivacaine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liposomal Bupivacaine Sales by Type
4.1.1 Global Liposomal Bupivacaine Historical Sales by Type (2019-2024)
4.1.2 Global Liposomal Bupivacaine Forecasted Sales by Type (2025-2030)
4.1.3 Global Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
4.2 Global Liposomal Bupivacaine Revenue by Type
4.2.1 Global Liposomal Bupivacaine Historical Revenue by Type (2019-2024)
4.2.2 Global Liposomal Bupivacaine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
4.3 Global Liposomal Bupivacaine Price by Type
4.3.1 Global Liposomal Bupivacaine Price by Type (2019-2024)
4.3.2 Global Liposomal Bupivacaine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Liposomal Bupivacaine Sales by Application
5.1.1 Global Liposomal Bupivacaine Historical Sales by Application (2019-2024)
5.1.2 Global Liposomal Bupivacaine Forecasted Sales by Application (2025-2030)
5.1.3 Global Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
5.2 Global Liposomal Bupivacaine Revenue by Application
5.2.1 Global Liposomal Bupivacaine Historical Revenue by Application (2019-2024)
5.2.2 Global Liposomal Bupivacaine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
5.3 Global Liposomal Bupivacaine Price by Application
5.3.1 Global Liposomal Bupivacaine Price by Application (2019-2024)
5.3.2 Global Liposomal Bupivacaine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Liposomal Bupivacaine Market Size by Type
6.1.1 US & Canada Liposomal Bupivacaine Sales by Type (2019-2030)
6.1.2 US & Canada Liposomal Bupivacaine Revenue by Type (2019-2030)
6.2 US & Canada Liposomal Bupivacaine Market Size by Application
6.2.1 US & Canada Liposomal Bupivacaine Sales by Application (2019-2030)
6.2.2 US & Canada Liposomal Bupivacaine Revenue by Application (2019-2030)
6.3 US & Canada Liposomal Bupivacaine Market Size by Country
6.3.1 US & Canada Liposomal Bupivacaine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Liposomal Bupivacaine Sales by Country (2019-2030)
6.3.3 US & Canada Liposomal Bupivacaine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Liposomal Bupivacaine Market Size by Type
7.1.1 Europe Liposomal Bupivacaine Sales by Type (2019-2030)
7.1.2 Europe Liposomal Bupivacaine Revenue by Type (2019-2030)
7.2 Europe Liposomal Bupivacaine Market Size by Application
7.2.1 Europe Liposomal Bupivacaine Sales by Application (2019-2030)
7.2.2 Europe Liposomal Bupivacaine Revenue by Application (2019-2030)
7.3 Europe Liposomal Bupivacaine Market Size by Country
7.3.1 Europe Liposomal Bupivacaine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Liposomal Bupivacaine Sales by Country (2019-2030)
7.3.3 Europe Liposomal Bupivacaine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Liposomal Bupivacaine Market Size
8.1.1 China Liposomal Bupivacaine Sales (2019-2030)
8.1.2 China Liposomal Bupivacaine Revenue (2019-2030)
8.2 China Liposomal Bupivacaine Market Size by Application
8.2.1 China Liposomal Bupivacaine Sales by Application (2019-2030)
8.2.2 China Liposomal Bupivacaine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Liposomal Bupivacaine Market Size by Type
9.1.1 Asia Liposomal Bupivacaine Sales by Type (2019-2030)
9.1.2 Asia Liposomal Bupivacaine Revenue by Type (2019-2030)
9.2 Asia Liposomal Bupivacaine Market Size by Application
9.2.1 Asia Liposomal Bupivacaine Sales by Application (2019-2030)
9.2.2 Asia Liposomal Bupivacaine Revenue by Application (2019-2030)
9.3 Asia Liposomal Bupivacaine Sales by Region
9.3.1 Asia Liposomal Bupivacaine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Liposomal Bupivacaine Revenue by Region (2019-2030)
9.3.3 Asia Liposomal Bupivacaine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Liposomal Bupivacaine Market Size by Type
10.1.1 Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Liposomal Bupivacaine Market Size by Application
10.2.1 Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Country
10.3.1 Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pacira Pharmaceuticals
11.1.1 Pacira Pharmaceuticals Company Information
11.1.2 Pacira Pharmaceuticals Overview
11.1.3 Pacira Pharmaceuticals Liposomal Bupivacaine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pacira Pharmaceuticals Liposomal Bupivacaine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pacira Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Liposomal Bupivacaine Industry Chain Analysis
12.2 Liposomal Bupivacaine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposomal Bupivacaine Production Mode & Process
12.4 Liposomal Bupivacaine Sales and Marketing
12.4.1 Liposomal Bupivacaine Sales Channels
12.4.2 Liposomal Bupivacaine Distributors
12.5 Liposomal Bupivacaine Customers
13 Market Dynamics
13.1 Liposomal Bupivacaine Industry Trends
13.2 Liposomal Bupivacaine Market Drivers
13.3 Liposomal Bupivacaine Market Challenges
13.4 Liposomal Bupivacaine Market Restraints
14 Key Findings in The Global Liposomal Bupivacaine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Liposomal Bupivacaine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 20ml
Table 3. Major Manufacturers of 10ml
Table 4. Global Liposomal Bupivacaine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Liposomal Bupivacaine Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Liposomal Bupivacaine Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Liposomal Bupivacaine Revenue Market Share by Region (2019-2024)
Table 9. Global Liposomal Bupivacaine Revenue Market Share by Region (2025-2030)
Table 10. Global Liposomal Bupivacaine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Liposomal Bupivacaine Sales by Region (2019-2024) & (K Units)
Table 12. Global Liposomal Bupivacaine Sales by Region (2025-2030) & (K Units)
Table 13. Global Liposomal Bupivacaine Sales Market Share by Region (2019-2024)
Table 14. Global Liposomal Bupivacaine Sales Market Share by Region (2025-2030)
Table 15. Global Liposomal Bupivacaine Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Liposomal Bupivacaine Sales Share by Manufacturers (2019-2024)
Table 17. Global Liposomal Bupivacaine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Liposomal Bupivacaine Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Liposomal Bupivacaine, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Liposomal Bupivacaine Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Liposomal Bupivacaine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Liposomal Bupivacaine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Bupivacaine as of 2023)
Table 23. Global Key Manufacturers of Liposomal Bupivacaine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Liposomal Bupivacaine, Product Offered and Application
Table 25. Global Key Manufacturers of Liposomal Bupivacaine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 28. Global Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 29. Global Liposomal Bupivacaine Sales Share by Type (2019-2024)
Table 30. Global Liposomal Bupivacaine Sales Share by Type (2025-2030)
Table 31. Global Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Liposomal Bupivacaine Revenue Share by Type (2019-2024)
Table 34. Global Liposomal Bupivacaine Revenue Share by Type (2025-2030)
Table 35. Liposomal Bupivacaine Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Liposomal Bupivacaine Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 38. Global Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 39. Global Liposomal Bupivacaine Sales Share by Application (2019-2024)
Table 40. Global Liposomal Bupivacaine Sales Share by Application (2025-2030)
Table 41. Global Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Liposomal Bupivacaine Revenue Share by Application (2019-2024)
Table 44. Global Liposomal Bupivacaine Revenue Share by Application (2025-2030)
Table 45. Liposomal Bupivacaine Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Liposomal Bupivacaine Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Liposomal Bupivacaine Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Liposomal Bupivacaine Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Liposomal Bupivacaine Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Liposomal Bupivacaine Sales by Country (2025-2030) & (K Units)
Table 60. Europe Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 61. Europe Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 62. Europe Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 65. Europe Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 66. Europe Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Liposomal Bupivacaine Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Liposomal Bupivacaine Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Liposomal Bupivacaine Sales by Country (2019-2024) & (K Units)
Table 72. Europe Liposomal Bupivacaine Sales by Country (2025-2030) & (K Units)
Table 73. China Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 74. China Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 75. China Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 78. China Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 79. China Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 82. Asia Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 83. Asia Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 86. Asia Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 87. Asia Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Liposomal Bupivacaine Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Liposomal Bupivacaine Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Liposomal Bupivacaine Sales by Region (2019-2024) & (K Units)
Table 93. Asia Liposomal Bupivacaine Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Country (2025-2030) & (K Units)
Table 107. Pacira Pharmaceuticals Company Information
Table 108. Pacira Pharmaceuticals Description and Major Businesses
Table 109. Pacira Pharmaceuticals Liposomal Bupivacaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Pacira Pharmaceuticals Liposomal Bupivacaine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pacira Pharmaceuticals Recent Developments
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Liposomal Bupivacaine Distributors List
Table 115. Liposomal Bupivacaine Customers List
Table 116. Liposomal Bupivacaine Market Trends
Table 117. Liposomal Bupivacaine Market Drivers
Table 118. Liposomal Bupivacaine Market Challenges
Table 119. Liposomal Bupivacaine Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomal Bupivacaine Product Picture
Figure 2. Global Liposomal Bupivacaine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Liposomal Bupivacaine Market Share by Type in 2023 & 2030
Figure 4. 20ml Product Picture
Figure 5. 10ml Product Picture
Figure 6. Global Liposomal Bupivacaine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Liposomal Bupivacaine Market Share by Application in 2023 & 2030
Figure 8. Veterinary
Figure 9. Human
Figure 10. Liposomal Bupivacaine Report Years Considered
Figure 11. Global Liposomal Bupivacaine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Liposomal Bupivacaine Revenue 2019-2030 (US$ Million)
Figure 13. Global Liposomal Bupivacaine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Liposomal Bupivacaine Revenue Market Share by Region (2019-2030)
Figure 15. Global Liposomal Bupivacaine Sales 2019-2030 ((K Units)
Figure 16. Global Liposomal Bupivacaine Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 18. US & Canada Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 20. Europe Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 22. China Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 24. Asia (excluding China) Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 26. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Liposomal Bupivacaine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Liposomal Bupivacaine in the World: Market Share by Liposomal Bupivacaine Revenue in 2023
Figure 29. Global Liposomal Bupivacaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 31. Global Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 32. Global Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 33. Global Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Liposomal Bupivacaine Revenue Share by Country (2019-2030)
Figure 39. US & Canada Liposomal Bupivacaine Sales Share by Country (2019-2030)
Figure 40. U.S. Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 43. Europe Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 44. Europe Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 45. Europe Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 46. Europe Liposomal Bupivacaine Revenue Share by Country (2019-2030)
Figure 47. Europe Liposomal Bupivacaine Sales Share by Country (2019-2030)
Figure 48. Germany Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 49. France Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 53. China Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 54. China Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 55. China Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 56. China Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 57. Asia Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 58. Asia Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 59. Asia Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 60. Asia Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 61. Asia Liposomal Bupivacaine Revenue Share by Region (2019-2030)
Figure 62. Asia Liposomal Bupivacaine Sales Share by Region (2019-2030)
Figure 63. Japan Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 67. India Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Liposomal Bupivacaine Sales Share by Country (2019-2030)
Figure 74. Brazil Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 79. Liposomal Bupivacaine Value Chain
Figure 80. Liposomal Bupivacaine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Table 1. Global Liposomal Bupivacaine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 20ml
Table 3. Major Manufacturers of 10ml
Table 4. Global Liposomal Bupivacaine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Liposomal Bupivacaine Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Liposomal Bupivacaine Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Liposomal Bupivacaine Revenue Market Share by Region (2019-2024)
Table 9. Global Liposomal Bupivacaine Revenue Market Share by Region (2025-2030)
Table 10. Global Liposomal Bupivacaine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Liposomal Bupivacaine Sales by Region (2019-2024) & (K Units)
Table 12. Global Liposomal Bupivacaine Sales by Region (2025-2030) & (K Units)
Table 13. Global Liposomal Bupivacaine Sales Market Share by Region (2019-2024)
Table 14. Global Liposomal Bupivacaine Sales Market Share by Region (2025-2030)
Table 15. Global Liposomal Bupivacaine Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Liposomal Bupivacaine Sales Share by Manufacturers (2019-2024)
Table 17. Global Liposomal Bupivacaine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Liposomal Bupivacaine Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Liposomal Bupivacaine, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Liposomal Bupivacaine Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Liposomal Bupivacaine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Liposomal Bupivacaine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Bupivacaine as of 2023)
Table 23. Global Key Manufacturers of Liposomal Bupivacaine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Liposomal Bupivacaine, Product Offered and Application
Table 25. Global Key Manufacturers of Liposomal Bupivacaine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 28. Global Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 29. Global Liposomal Bupivacaine Sales Share by Type (2019-2024)
Table 30. Global Liposomal Bupivacaine Sales Share by Type (2025-2030)
Table 31. Global Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Liposomal Bupivacaine Revenue Share by Type (2019-2024)
Table 34. Global Liposomal Bupivacaine Revenue Share by Type (2025-2030)
Table 35. Liposomal Bupivacaine Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Liposomal Bupivacaine Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 38. Global Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 39. Global Liposomal Bupivacaine Sales Share by Application (2019-2024)
Table 40. Global Liposomal Bupivacaine Sales Share by Application (2025-2030)
Table 41. Global Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Liposomal Bupivacaine Revenue Share by Application (2019-2024)
Table 44. Global Liposomal Bupivacaine Revenue Share by Application (2025-2030)
Table 45. Liposomal Bupivacaine Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Liposomal Bupivacaine Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Liposomal Bupivacaine Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Liposomal Bupivacaine Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Liposomal Bupivacaine Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Liposomal Bupivacaine Sales by Country (2025-2030) & (K Units)
Table 60. Europe Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 61. Europe Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 62. Europe Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 65. Europe Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 66. Europe Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Liposomal Bupivacaine Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Liposomal Bupivacaine Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Liposomal Bupivacaine Sales by Country (2019-2024) & (K Units)
Table 72. Europe Liposomal Bupivacaine Sales by Country (2025-2030) & (K Units)
Table 73. China Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 74. China Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 75. China Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 78. China Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 79. China Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 82. Asia Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 83. Asia Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 86. Asia Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 87. Asia Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Liposomal Bupivacaine Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Liposomal Bupivacaine Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Liposomal Bupivacaine Sales by Region (2019-2024) & (K Units)
Table 93. Asia Liposomal Bupivacaine Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Liposomal Bupivacaine Sales by Country (2025-2030) & (K Units)
Table 107. Pacira Pharmaceuticals Company Information
Table 108. Pacira Pharmaceuticals Description and Major Businesses
Table 109. Pacira Pharmaceuticals Liposomal Bupivacaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Pacira Pharmaceuticals Liposomal Bupivacaine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pacira Pharmaceuticals Recent Developments
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Liposomal Bupivacaine Distributors List
Table 115. Liposomal Bupivacaine Customers List
Table 116. Liposomal Bupivacaine Market Trends
Table 117. Liposomal Bupivacaine Market Drivers
Table 118. Liposomal Bupivacaine Market Challenges
Table 119. Liposomal Bupivacaine Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomal Bupivacaine Product Picture
Figure 2. Global Liposomal Bupivacaine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Liposomal Bupivacaine Market Share by Type in 2023 & 2030
Figure 4. 20ml Product Picture
Figure 5. 10ml Product Picture
Figure 6. Global Liposomal Bupivacaine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Liposomal Bupivacaine Market Share by Application in 2023 & 2030
Figure 8. Veterinary
Figure 9. Human
Figure 10. Liposomal Bupivacaine Report Years Considered
Figure 11. Global Liposomal Bupivacaine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Liposomal Bupivacaine Revenue 2019-2030 (US$ Million)
Figure 13. Global Liposomal Bupivacaine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Liposomal Bupivacaine Revenue Market Share by Region (2019-2030)
Figure 15. Global Liposomal Bupivacaine Sales 2019-2030 ((K Units)
Figure 16. Global Liposomal Bupivacaine Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 18. US & Canada Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 20. Europe Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 22. China Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 24. Asia (excluding China) Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Liposomal Bupivacaine Sales YoY (2019-2030) & (K Units)
Figure 26. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Liposomal Bupivacaine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Liposomal Bupivacaine in the World: Market Share by Liposomal Bupivacaine Revenue in 2023
Figure 29. Global Liposomal Bupivacaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 31. Global Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 32. Global Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 33. Global Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Liposomal Bupivacaine Revenue Share by Country (2019-2030)
Figure 39. US & Canada Liposomal Bupivacaine Sales Share by Country (2019-2030)
Figure 40. U.S. Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 43. Europe Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 44. Europe Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 45. Europe Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 46. Europe Liposomal Bupivacaine Revenue Share by Country (2019-2030)
Figure 47. Europe Liposomal Bupivacaine Sales Share by Country (2019-2030)
Figure 48. Germany Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 49. France Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 53. China Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 54. China Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 55. China Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 56. China Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 57. Asia Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 58. Asia Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 59. Asia Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 60. Asia Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 61. Asia Liposomal Bupivacaine Revenue Share by Region (2019-2030)
Figure 62. Asia Liposomal Bupivacaine Sales Share by Region (2019-2030)
Figure 63. Japan Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 67. India Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Liposomal Bupivacaine Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Liposomal Bupivacaine Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Liposomal Bupivacaine Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Liposomal Bupivacaine Sales Share by Country (2019-2030)
Figure 74. Brazil Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Liposomal Bupivacaine Revenue (2019-2030) & (US$ Million)
Figure 79. Liposomal Bupivacaine Value Chain
Figure 80. Liposomal Bupivacaine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232